preview

Research On Parkinson's Disease

Better Essays
Results

This systematic search and reviewed three health and medically related databases to find 15 articles relating to elders with Parkinson’s disease. Of the 15 articles occupational therapy and drug therapy were used to decrease the symptoms of Parkinson’s disease. Some of the articles had found similar findings, but varied in different aspects.
The two tables in this section discuss the main findings of research done on Parkinson’s Disease in regards to the effectiveness of different treatment options. Specifically, occupational therapy and drug therapy. Table 1 discusses the studies related to elderly Parkinson’s patients and how up and coming occupational therapy methods were used to improve or alleviate the ongoing symptoms that are
…show more content…
(2015) study. A case-control study using exposure to whole body vibration (WBV) was conducted. There were 403 cases and 405 control in this study. Adjustments were made according to the patient’s age, sex and if they are a smoker or had a head injury in the past. This is the only occupational study that did not help patients with PD. Lower levels of WBV could possibly help patients, higher levels of WBV could potentially damage the patient. WBV could potentially damage patients with PD by resulting in micro-injury, leading to vascular or inflammatory pathology in neurons.
Table 2 discusses the studies related to clinical trials using different drug treatments and placebos that were targeted at one specific symptom of Parkinson’s disease. The studies were used to determine the effects of the drug and if these effects had a positive outcome on the symptom that researchers were trying to alleviate. A total of eight studies were found that at examined the effectiveness of drug therapy on patients diagnosed with
…show more content…
This is a non-motor symptom in Parkinson’s patients but is quite significant. This study used Safinamide which is an up and coming drug taken with Levodopa which was taken by fluctuating Parkinson’s patients. This study took place over a period of 24 months, double blind, and placebo controlled. Two data sets were used to assess the benefits of Safinamide on patients with serious pain. The Parkinson’s Disease Quality of Life Questionnaire was used to determine pain complaints in the patients before and after the study. The data concluded that those patients treated with 100 mg Safinamide/day had significantly decreased pain complaints and use of other pain medications by almost 24%. Two out of three pain related items on the Questionnaire were also significantly
Get Access